Red Pharma Healthcaresp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-11-20
Share capital
50 000,00 PLN
Registered address
ul. Słoneczna 116 A, 05-500 Stara Iwiczna, Poland
Website
red-pharma.comWebsite active

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 382.13kMedianUSD 1.75mAverageUSD 5.00m
Net profit
This companyUSD 13.50MedianUSD 17.49kAverageUSD 85.24k
Operating costs
This companyUSD 378.90kMedianUSD 1.72mAverageUSD 4.85m
Assets
This companyUSD 207.21kMedianUSD 495.38kAverageUSD 1.71m

Bank accounts

Registered as a VAT taxpayer on 2017-11-23. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,294

Tenders

No recorded participation in tenders.

Trademarks

Red Pharma Healthcare holds 9 active trademarks registered with the Polish Patent Office. 5 marks have expired or were not registered. The first mark was filed in 2018.

MarkProtected until
Vitaminum H+B5 krem H+B5Nov 17, 2032
Vitaminum E + Szałwia żel z mentolem E+SZJun 29, 2032
BactiStrepsNov 19, 2031
Mocznik 50% REGENERATION Urea serumOct 5, 2031
Vitaminum D+F krem D+FOct 5, 2031

Authorized Representatives

Krzysztof Zbigniew Łuba – Vice President of the Management Board
Rafał Piotr Prejsnar – President of the Management Board

Manner of representation

Joint action by two members of the management board or by one member of the management board together with a commercial proxy is required to make declarations of will on behalf of the company.

Ownership

OwnerSharesShare valueStake
500$6,753.1150%
400$5,402.4940%
100$1,350.6210%

Beneficial owners

Person

Subsidiaries

NameStake
89%

Competitors

Name
DR ZdrowieS.A.
MagmaxS.A.
Adpharmasp. z o.o.
Novopharm - Millersp. j.
MaglowS.A.
Farmacja Im. O. Klimuszkisp. z o.o.
Nukloversp. z o.o.
Massmedsp. z o.o.
DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A.
Femaherbsp. z o.o.

Change history

DateEvent
2019-05-31Address change
2019-05-31Share capital change
2017-11-20Entered in the register

FAQ

Last updated: 2026-04-26